The global surgical robotics market was valued at $56,294.9 million in 2017, and is expected to reach $98,737.0 million by 2024 at a CAGR of 8.5% during the forecast period. Robotic surgery is a type of minimally invasive surgery which utilizes robotics for performing surgical procedures. These robotic systems are operated by surgeons and consists of miniaturized surgical instruments which are mounted on robotic arms, thus allowing surgeons to perform the surgeries precisely.
The future growth study of top industry players operating in the global surgical robotics market includes
- Smith & Nephew Plc. (Blue Belt Technologies, Inc.)
- Auris Surgical Robotics Inc. (Hansen Medical Inc.)
- Intuitive Surgical, Inc.
- KUKA AG
- Stryker Corporation (MAKO Surgical Corp.)
- Mazor Robotics
- Renishaw plc.
- THINK Surgical, Inc., and
- Zimmer Biomet Holdings Inc.
Other players operating in the value chain are Transenterix, Verb Surgical, Titan Medical, Microbot Medical, Accuray, and Medrobotics.
Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/852
1. Surgical robotics market size and forecast
The global Surgical Robotics Market was valued at $56,294.9 million in 2017 and is expected to reach $98,737.0 million by 2024 at a CAGR of 8.5% during the forecast period.
2. The shifting surgical robotics market
The key factors driving the growth of the surgical robotics market is the increasing need for automation in the healthcare industry and the shifting trend towards advanced robotic surgeries. However, the high cost associated with surgical robotic surgeries & robotic systems will hamper market growth. Additionally, dearth of trained healthcare professionals impede the growth of the surgical robotics market. Moreover, untapped economies such as Brazil, India, China, and other developing economies will create lucrative opportunities in the surgical robotics market.
A surgical robotic system is a technologically advanced surgical solution, used mainly during complicated surgical procedures. The surgical robotic system includes surgeons console, surgical arms, and monitoring systems & software. The surgical robotic system market is gaining prominence in recent years owing to rapid technological advancements, increasing investments in research and development and its extensive application in critical surgeries such as cardiac, orthopedic and neurosurgery. Further, wide scope of applications in different surgeries, increasing demands for advanced medical facilities and rising incidence of diseases such as cancer and musculoskeletal ailments & injuries, majorly supplement the growth of surgical robotics market. On the contrary, high costs of surgical robotic procedures, lack of awareness and inadequate presence of expert professionals are major factors impeding the market growth.
3. The growing segment of the surgical robotics market
The global surgical robotics market is segmented into component, surgery type, and region. Based on component, the market is segmented into systems, accessories, and services. The surgical robotics market based on surgery type is segmented into gynecology surgery, urology surgery, neurosurgery, orthopedic surgery, general surgery, and others. Regionally the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
4. The size of the component segment in the surgical robotics market
In terms of revenue, the accessories in component segment accounted for the highest market share in 2017, owing to rising adoption of surgical robotic systems across Tier-1 hospitals, recurrent sales of accessories for these systems and demand for highly efficient replaceable components. Surgical robotic systems services would emerge as the lucrative segment since it is mandatory for every surgical robotic systems buyer to maintain the system’s performance. The services segment would exhibit the fastest growth rate, registering a CAGR of 15.7% during the forecast period.
Based on surgery type, the neurosurgery segment accounted for about one-sixth share of the total market in terms of value as well as volume and is expected to grow at a CAGR of 8.6% and 6.5% respectively during the forecast period. As robotic systems were primarily used for neurosurgeries and later widen its application. The need for precision during neurosurgery has led to an increase in adoption for surgical robotics.
5. Key Findings of the Surgical Robotics Market
- The gynecology surgery accounted for about one-sixth share of the global market in terms of revenue as well as volume in 2017.
- The surgical systems segment by component accounted for one-third share of the global market in 2017 and is expected to grow at a CAGR of 11.3% during the forecast period.
- The U.S. dominated the North American surgical robotics market in 2017 by surgery type and is projected to grow at a CAGR of 7.0% during the forecast period.
- Spain is expected to be the fastest-growing country in the European surgical robotics market by surgery type with a CAGR of 12.3% during 2018-2024.
- India is expected to be the fastest-growing country in the Asia-Pacific surgical robotics market by surgery type during the forecast period.
6. The untapped North America market for Surgical Robotics Market
North America dominated the surgical robotics market. The market growth in North America is primarily a reflection of product innovations and launches resulting from technological advancements. The companies mostly adopted product launch, acquisition, and expansion as their key strategies to keep pace with the changing demands of consumers and strengthen their market position.
|By Surgery Type||Gynecology Surgery|
|By Geography||North America|
|Scope of the Report:|
|Market size available for years||2017 – 2024|
|Base year considered||2018|
|Forecast period||2017 – 2024|
|Forecast units||Value (USD)|
|Segments covered||By Component, by Surgery Type, and by Geography|
|Geographies covered||North America, Europe, Asia-Pacific, LAMEA|
Access Full Summary @ https://www.alliedmarketresearch.com/press-release/surgical-robotics-market.html
TAVI Market Expected to Reach $8,138 Million, By 2025
Migraine Drugs Market Expected to Reach $2,190 Million, By 2025
PEGylated Protein Therapeutics Market Expected to Reach $17,813 Million, By 2025
Surgical Equipment Market Expected to Reach $15,737.1 Million by 2023
Mass Spectrometry Market Expected to Reach $7,922 Million by 2023
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Follow Us on Twitter: https://twitter.com/marketresearcht